We are live on ! Find out more
VECT

VectivBio Holding AG Ordinary Shares
VECT

Delisted

VECT was delisted on the 7th of July, 2023.

Back to rankings

2 hedge funds and large institutions have $520K invested in VectivBio Holding AG Ordinary Shares in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 48 closing their positions.

New
Increased
Maintained
Reduced
Closed

96% less funds holding

Funds holding: 49 → 2 (-47)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 48

100% less capital invested

Capital invested by funds: $504M → $520K (-$503M)

100% less funds holding in top 10

Funds holding in top 10: 7 → 0 (-7)

Holders
2
Holders Change
-47
Holders Change %
-95.92%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-7
Holding in Top 10 Change %
-100%
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
48
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SOW
State of Wyoming
Wyoming
+$14.7K

Top Sellers

Rank Fund Capital Flow
1
O
OrbiMed
New York
-$87.7M
2
TCM
TCG Crossover Management
California
-$52.9M
3
CA
CHI Advisors
New York
-$46.9M
4
VC
Vivo Capital
California
-$39.4M
5
GCL
Glazer Capital LLC
New York
-$31.9M

VECT Hedge Fund Activity: Q3 2023 in Review

2 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in VectivBio Holding AG Ordinary Shares (VECT) for Q3 2023, worth a combined $520K — down 100% from $504M a quarter earlier.

Sellers outnumbered buyers: 48 funds closed out of VECT and 1 opened new positions — a net loss of 47 holders — while 0 trimmed existing stakes and 0 added.

The largest buyer was State of Wyoming, opening a new position worth an estimated $14.7K. The largest seller was OrbiMed, exiting entirely with an estimated $87.7M sold.

  • 2 institutional investors held VectivBio Holding AG Ordinary Shares (VECT) as of Q3 2023, down from 49 in Q2 2023.
  • Funds reported $520K of VectivBio Holding AG Ordinary Shares stock for Q3 2023, down 100% quarter-over-quarter.
  • 1 fund opened new VectivBio Holding AG Ordinary Shares positions in Q3 2023 and 48 closed out, a net change of -47 holders.
  • The largest VectivBio Holding AG Ordinary Shares buyer in Q3 2023 was State of Wyoming, an estimated $14.7K added.
  • The largest VectivBio Holding AG Ordinary Shares seller in Q3 2023 was OrbiMed, an estimated $87.7M sold.

Based on aggregated 13F filings for Q3 2023.